Our Mission is to harness the power of Artificial Intelligence to ensure that the faster and earlier detection of breast cancers can help to save more women’s lives.

Our aim is also to use AI to help radiologists identify breast cancers as early as possible so that earlier treatment will increase the likelihood of success and reduce unnecessary recalls.

Transpara Breast Care is the brainchild of two of the world’s most renowned experts in the field who brought their knowledge of cutting-edge medicine, physics and artificial intelligence to optimize the early diagnosis of breast cancer.

Professor Sir Michael Brady of MIT and Oxford University in England and Professor Nico Karssemeijer of the University of Nijmegen in The Netherlands founded ScreenPoint Medical, developers of Transpara AI.